Loading...
NPI 1558412320 · Portland, OR · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Crc Health Oregon, LLC is a methadone clinic provider located in Portland, Oregon. This profile covers 4 Medicare and 19 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Crc Health Oregon, LLC |
| Address | 2600 Se Belmont St |
| City | Portland |
| State | OR |
| ZIP | 97214 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | January 16, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $24.3M |
| Medicare | $177.6K |
CRC HEALTH OREGON, LLC is operating as an opioid treatment program focused on medication‑assisted treatment: its Medicare top procedures are concentrated in OTP weekly bundles and take‑home methadone supply (G2067, G2078, G2074), and its Medicaid top procedures are dominated by methadone administration and high-volume counseling and testing (H0020, H0005, H0048). The specific code mix — weekly bundled treatment, take‑home supplies, group counseling, and specimen collection — is consistent with a clinic that dispenses methadone on a large scale while providing counseling and toxicology support on site. The provider’s city/state of record is PORTLAND, OR, which contextualizes the in‑state rank comparisons reported below.
Revenue is highly concentrated within a few OTP codes on both payers. Precomputed totals show the top 3 Medicare codes by revenue account for 99.1% of the provider’s total Medicare revenue, indicating nearly all Medicare receipts come from a narrow set of OTP services. Likewise, the top 3 Medicaid codes by revenue account for 78.3% of total Medicaid revenue, showing a strong but somewhat broader concentration around methadone administration, group counseling, and drug testing.
Payer mix is heavily skewed to Medicaid: the provider reported Total Medicaid revenue of $24.3M versus Total Medicare revenue of $177.6K. This dollar contrast makes the operation effectively Medicaid‑driven in scale and suggests payer strategy, contracting, and capacity decisions will be most consequential with Medicaid payers rather than Medicare. Analysts should therefore prioritize Medicaid utilization and reimbursement patterns when assessing financial and operational risk.
Medicaid competitive standing is dominant in Oregon for core OTP services. The provider ranks #1 of 32 in‑state for H0020 (1.5M claims, $6 avg paid/claim, $8.8M revenue; described as notably above typical state volume), and ranks in the top few statewide for H0005 (rank #3 of 184; 155.7K claims, $41 avg, $6.4M; labeled an extreme outlier) and H0048 (rank #2 of 162; 159.6K claims, $22 avg, $3.5M; labeled an extreme outlier). These ranks and labels indicate the clinic is a major, high‑volume provider of methadone administration, group counseling, and testing services within Oregon.
By contrast, Medicare activity is limited and not dominant nationally. The single largest Medicare code, G2067 (566 claims, $245 avg paid/claim, $138.7K revenue), accounts for the majority of Medicare revenue but ranks #477 of 830 providers nationally (43rd percentile), while G2078 ranks at the 70th percentile and G2074 at the 51st percentile. Those percentiles and the precomputed 99.1% concentration imply the clinic participates in Medicare OTP billing but without a standout national footprint; Medicare representational volume is typical to modest for these OTP codes.
Operational profile implied by unit economics and claims mix: on Medicaid the provider reports extreme claim volumes at low per‑claim payments (for example H0020 at 1.5M claims with $6 avg paid/claim generating $8.8M), which is consistent with high-frequency daily or near‑daily medication administration and centralized dispensing workflows. Coupled with large counts for H0005 (group counseling) and H0048 (specimen collection), the pattern suggests a throughput‑oriented clinic model that pairs medication dispensing with bundled counseling and testing services rather than sporadic episodic visits.
Tenure and provider stability are long enough to have established referral and payer relationships: the NPI was enumerated on 2007-01-16 (~19 years ago). That longevity, together with the reported high statewide volumes for core Medicaid OTP codes, supports the interpretation of a well‑established regional operator rather than a recent entrant.
There are clear statistical outlier signals in the Medicaid data that merit attention for network and policy analysis. H0005 and H0048 are both reported as “extreme outlier, far above typical state volume,” and H0020 and H0004 are “notably above typical state volume”; these qualitative labels and the top ranks indicate unusually concentrated service delivery in a few OTP activities relative to in‑state peers, which could affect capacity, access, and contracting dynamics in the local behavioral‑health/methadone market.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 570 | $250 | $138.7K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 560 | $40 | $21.2K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 80 | $200 | $16.2K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and… | 10 | $120 | $1.6K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 4 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
19 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1,469,430 | $10 | $8.8M |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 155,740 | $40 | $6.4M |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 159,580 | $20 | $3.5M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 68,440 | $50 | $3.4M |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 5,500 | $80 | $412.6K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 35,770 | $10 | $357.7K |
| J0571 | Buprenorphine, oral, 1 mg | 28,700 | $10 | $315.7K |
| T1502 | Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit | 34,850 | $10 | $209.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,630 | $80 | $199.9K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 18,740 | $10 | $131.2K |
Showing 1–10 of 19
How this provider's Medicaid billing volume and revenue compare to other Oregon providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oregon median
19 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 1 | 30 | 86,800 | $10 | $2.4M |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 3 | 180 | 3,250 | $40 | $783.8K |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 8 | 270 | 1,660 | $90 | $681K |
| H0033 | Oral medication administration, direct observation | 10 | 20 | 4,620 | $10 | $521.2K |
| J0571 | Buprenorphine, oral, 1 mg | 3 | 10 | 3,000 | $10 | $475.6K |
| J0574 | Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine | 2 | 10 | 9,110 | $10 | $454.8K |
| H0038 | Self‑help/peer services, per 15 minutes | 82 | 150 | 1,030 | $80 | $417.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 727 | 1,500 | 650 | $70 | $312.4K |
| J0572 | Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine | 2 | 10 | 4,600 | $20 | $309.8K |
| H0016 | Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) | 7 | 20 | 1,840 | $70 | $256.9K |
Showing 1–10 of 19
Other providers in the same ZIP code as Crc Health Oregon, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.